Grassley, Durbin, Tillis, Coons introduce legislation to strengthen coordination between Patent Office, FDA

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Sens. Chuck Grassley (R-IA), Dick Durbin (D-IL), chair of the Senate Judiciary Committee, Thom Tillis (R-NC), and Chris Coons (D-DE) to introduce bipartisan legislation that would establish a task force between the United States Patent and Trademark Office and FDA to improve communication and coordination in implementing each agency’s activities related to patents. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Last week, FDA granted accelerated approval to Replimune Group Inc. for it’s biologic, RP1 (vusolimogene oderparepvec), following the FDA Cellular, Tissue, and Gene Therapies Advisory Committee’s 10:3 vote in support of the biologic in combination with nivolumab for the treatment of advanced melanoma in patients who have progressed on prior anti-PD-1 therapy.
FDA has granted an accelerated approval to RP1 (vusolimogene oderparepvec) following the agency’s Cellular, Tissue, and Gene Therapies Advisory Committee’s 10:3 vote in support of the biologic in combination with nivolumab for the treatment of advanced melanoma in patients who have progressed on prior anti-PD-1 therapy.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login